The company, a leading designer and manufacturer of rapid diagnostic screening and testing products, said the new technology provides a key element for some of its diagnostic tests, and that it can also be used in other diagnostic tests not only in clinical laboratories, but also at the point-of-care.
The technology helps enable the rapid blood cell separation of small volumes of whole blood, including those obtained from finger stick samples.
Serum or plasma samples are extracted within minutes and are ready for immediate analysis by rapid assay devices, such as Akers Biosciences' own products, and can deliver valuable real-time results, the company said in a statement.
The biosciences group said that conventional methods of blood separation are labour-intensive and time consuming, and usually involve blood collection and laboratory personnel as well as electrically-
"We believe that the technology provides a significant step forward in the development of point-of-care diagnostic tests which could benefit not only ABI's products, but those of the wider point-of-care diagnostic community," Akers Biosciences' executive chairman Dr. Raymond Akers said.
Author: Paul Chapman, analyst.
Please click here for additional information:
# # #
Browse 450,000 market research reports and company profiles covering major markets, companies and countries. www.companiesandmarkets.com is a central source of market research reports from the world’s leading analysts and report publishers.